Skip to content
healthcare.dev

Skyrizi

NDC 0074-1070, Risankizumab-rzaa, kit, from AbbVie Inc..

Product NDC
0074-1070
Status
Listed
Labeler
AbbVie Inc.
Dosage form
KIT
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761105
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0074-1070 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
0074-1070-01000741070011 KIT in 1 CARTON (0074-1070-01) * 2.4 mL in 1 CARTRIDGE (0074-1069-02) * 2.4 mL in 1 CARTRIDGE (0074-1069-01)
0074-1070-02000741070021 KIT in 1 CARTON (0074-1070-02) * 2.4 mL in 1 CARTRIDGE (0074-1069-02) * 2.4 mL in 1 CARTRIDGE (0074-1069-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7148c8eb-b39e-e20a-6494-a6df82392858
  • NADAC price for package 00074107001

    GET /v1/drugs/nadac/00074107001

Use it

Look up 0074-1070 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0074-1070 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0074-1070. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.